FRANKLIN, Mass., June 23 /PRNewswire/ -- Arthrosurface, Inc. (www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has received the CE Mark approval for its UniCAP(TM) Unicondylar resurfacing system. With this approval, the company is poised to move into the fast growing European market of partial knee replacements. “We have taken our clinical experiences from the company’s HemiCAP(R) focal knee resurfacing product in Europe, in part, to create a larger sized Unicondylar knee system that is joint preserving while having the fit of a device similar to an off-the-shelf custom implant”, said Steve Ek, COO.
Many patients with knee arthritis have damage on only one side of their knee. If detected early, damage to the cartilage surface is often localized and the meniscus, the main shock absorbing structure of the knee joint, may still be functional. “What makes the UniCAP(TM) system unique is that it is the only Unicondylar knee system on the market that allows for the preservation of the soft tissues about the knee, including the meniscus, and preserves the healthy tissues and bone in the knee. In addition, the ability to perform the procedure as an arthroscopically assisted surgery will benefit the patient, especially for those that continue an active lifestyle”, commented Anthony Miniaci, M.D. of the Cleveland Clinic.
The company believes that its product lines address a gap in existing treatments, specifically between biological options and joint replacement. The company maintains that biological treatments, such as grafting and cell regeneration, may be viable options for those that are young; alternatively total joint replacement surgery may be effective for those that are much older or less active. It is the Millennium Patient(TM), a typical middle-aged and active patient as termed by the company, that may not be suited for either of these options. The UniCAP(TM) system may now provide an option for this previously unaddressed market.
“With the development of the different Arthrosurface systems over the past five years, we have effectively become the new joint preservation company for the orthopaedic surgeon”, summarized Steve Ek.
CONTACT: Anthony C. Moretti, CFO of Arthrosurface, Inc., +1-508-520-3003
Web site: http://arthrosurface.com/
